Costs in English law

Scott+Scott Attorneys at Law LLP, Levi & Korsinsky, LLP, and Wolf Popper LLP Issue Summary Notice of Proposed Settlement of Class Action

Retrieved on: 
Monday, September 6, 2021

THIS NOTICE WAS AUTHORIZED BY THE COURT AND EXPLAINS HOW YOUR RIGHTS MAY BE AFFECTED BY A PROPOSED CLASS ACTION SETTLEMENT.

Key Points: 
  • THIS NOTICE WAS AUTHORIZED BY THE COURT AND EXPLAINS HOW YOUR RIGHTS MAY BE AFFECTED BY A PROPOSED CLASS ACTION SETTLEMENT.
  • The Court may adjourn or continue the Settlement Hearing or hold the Settlement Hearing by telephonic or video conference without further notice to members of the Settlement Class.
  • Any change to the Settlement Hearing date, time, or manner will be posted on the settlement website ( www.WideOpenWestSecuritiesSettlement.com ).
  • This Summary Notice provides only a summary of matters regarding the Litigation and the Settlement.

Vivid Seats Releases First Quarter 2021 Update

Retrieved on: 
Friday, May 28, 2021

During the three months ended March 31, 2021, Vivid Seats incurred transaction costs related to the Transactions.

Key Points: 
  • During the three months ended March 31, 2021, Vivid Seats incurred transaction costs related to the Transactions.
  • Vivid Seats incurs equity-based compensation expenses, which it does not consider to be indicative of its core operating performance.
  • These expenses relate to external legal costs and settlement costs incurred, which were unrelated to Vivid Seats core business operations.
  • During August 2019, Vivid Seats initiated the Vivid Seats Rewards customer loyalty program.

One Heritage Group plc: Signing construction finance facility

Retrieved on: 
Friday, May 21, 2021

The Facility is drawn down as construction costs are incurred on Oscar House.\nOscar House is a development of 27 self-contained apartments in central Manchester with a gross development value of \xc2\xa36.1 million.

Key Points: 
  • The Facility is drawn down as construction costs are incurred on Oscar House.\nOscar House is a development of 27 self-contained apartments in central Manchester with a gross development value of \xc2\xa36.1 million.
  • Winworth Construction Limited is the principal contractor on the site and construction work has already commenced.
  • One Heritage expects the development to finish in Q1 2022.
  • The remaining costs for Oscar House are being funded through existing resources.\nOne Heritage is continuing discussions with lenders for its other developments.\n'

Pacific Health Care Organization, Inc. Issues Corrective Press Release Regarding First Quarter 2021 Results

Retrieved on: 
Wednesday, May 19, 2021

Workers\xe2\x80\x99 compensation costs continue to increase due to rising medical costs, inflation, fraud and other factors.

Key Points: 
  • Workers\xe2\x80\x99 compensation costs continue to increase due to rising medical costs, inflation, fraud and other factors.
  • Medical and indemnity costs associated with workers\xe2\x80\x99 compensation in the state of California are billions of dollars annually.
  • \xc2\xa0Therefore, actual results and trends may differ materially from what is forecast in any forward-looking statement due to a variety of factors.
  • You may also view our annual report on Form 10-K on our website at http://www.pacifichealthcareorganization.com .\n'

Zentalis Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update

Retrieved on: 
Monday, May 17, 2021

A fourth CTA was submitted earlier this month for ZN-d5.\nIn February 2021, Zentalis entered into a strategic collaboration with Tempus to leverage its patient-derived organoid biological modeling platform to aid Zentalis in discovering and developing novel oncology therapies.

Key Points: 
  • A fourth CTA was submitted earlier this month for ZN-d5.\nIn February 2021, Zentalis entered into a strategic collaboration with Tempus to leverage its patient-derived organoid biological modeling platform to aid Zentalis in discovering and developing novel oncology therapies.
  • In addition, in the three months ended March\xc2\xa031, 2021, we conducted additional preclinical studies, incurred additional manufacturing costs, and incurred increased costs for study and lab materials.
  • Zentalis has licensed ZN-c5, ZN-c3 and ZN-d5 to its majority-owned joint venture, Zentera Therapeutics, to develop and commercialize these candidates in China.
  • Any such forward-looking statements represent management\xe2\x80\x99s estimates as of the date of this press release.

Westwater Resources Announces First Quarter March 31, 2021 Results

Retrieved on: 
Thursday, May 13, 2021

For the three-month period ended March 31, 2021, $1.8 million was spent on product development.

Key Points: 
  • For the three-month period ended March 31, 2021, $1.8 million was spent on product development.
  • For the three months ended March 31, 2021 general and administrative expenses increased by $0.3 million from the respective period in 2020.
  • The difference is primarily due to increased legal and consulting expenses related to the Company\xe2\x80\x99s Coosa Graphite Project.\nArbitration Costs.
  • During the first quarter of 2021, Westwater incurred arbitration related legal and expert consulting costs of $1.5 million.

Mandalay Resources Corporation Announces Financial Results for the First Quarter of 2021

Retrieved on: 
Wednesday, May 12, 2021

Actual results and developments may differ materially from those contemplated by these statements depending on, among other things, changes in commodity prices and general market and economic conditions.

Key Points: 
  • Actual results and developments may differ materially from those contemplated by these statements depending on, among other things, changes in commodity prices and general market and economic conditions.
  • The factors identified above are not intended to represent a complete list of the factors that could affect Mandalay.
  • This definition was updated in the third quarter of 2020 to exclude corporate general and administrative expenses to better align with industry standard.
  • A reconciliation between cost of sales and cash costs, and also cash cost to all-in sustaining costs are included in the MD&A.\n'

Predictive Oncology Reports Financial Results for Quarter Ended March 31, 2021 and Provides Business Update

Retrieved on: 
Wednesday, May 12, 2021

Our margins decreased in the current year as costs were higher, which more than offset the revenue earned in the current period.\nOur (G&A) expenses increased by $442,301 for the three months ended March 31, 2021 compared to 2020.

Key Points: 
  • Our margins decreased in the current year as costs were higher, which more than offset the revenue earned in the current period.\nOur (G&A) expenses increased by $442,301 for the three months ended March 31, 2021 compared to 2020.
  • The increase was primarily due to higher costs related to staff and higher AI computing costs.\nThe Company continues to decrease sales and marketing expenses, dropping $149,768 to $114,641 in the three months ended March 31, 2021.
  • Such expenses related almost exclusively to the Skyline Medical business.
  • Except as expressly required by law, the Company disclaims any intent or obligation to update these forward-looking statements.\n'

Accel Entertainment Announces Q1 2021 Operating Results

Retrieved on: 
Monday, May 10, 2021

Future cash payments do not include cash costs associated with renewing customer contracts as Accel does not generally incur significant costs as a result of extension or renewal of an existing contract.

Key Points: 
  • Future cash payments do not include cash costs associated with renewing customer contracts as Accel does not generally incur significant costs as a result of extension or renewal of an existing contract.
  • Markets are no longer considered emerging when Accel has installed or acquired at least 500 gaming terminals in the jurisdiction, or when 24 months have elapsed from the date Accel first installs or acquires gaming terminals in the jurisdiction, whichever occurs first.\nAccel will host an investor conference call on May 11, 2021 at 11 a.m. Central (12 p.m. Eastern) to discuss these operating and financial results.
  • Accordingly, forward-looking statements, including any projections or analysis, should not be viewed as factual and should not be relied upon as an accurate prediction of future results.
  • The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on the Accel.

Delaware Chancery Court Grants TransPerfect’s Request to Reduce Unreasonable Fees Billed by Skadden

Retrieved on: 
Tuesday, May 4, 2021

Practices included multi-million dollar\xc2\xa0invoices labeled with only \xe2\x80\x9clegal services,\xe2\x80\x9d containing no specificity or support for the alleged work.

Key Points: 
  • Practices included multi-million dollar\xc2\xa0invoices labeled with only \xe2\x80\x9clegal services,\xe2\x80\x9d containing no specificity or support for the alleged work.
  • During the company\'s eight-year battle in the Chancery Court, Bouchard and the Delaware Courts forced TransPerfect owners to spend approximately $244 million in legal and custodian fees so that one partner could be bought out for $285 million in after-tax value.
  • This amount was less than many voluntary offers to settle the dispute dating as far back as 2016.\nU.S.
  • District Court Judge Mark Kearney recently ruled that Chancellor Bouchard had "ordered TransPerfect to pay approximately $44.5 million in undocumented fees and costs."